ELI LILLY AND COMPANY |
Market Closed -
Other stock markets
|
After market 00:00:06 | |||
| 901.3 USD | -0.37% |
|
903.4 | +0.24% |
Presenter SpeechJacob Van Naarden (Executives)All right. Can everyone hear me, yes. Okay. I th...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
08/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +54.61% | 811B | |
| +44.25% | 640B | |
| -6.33% | 353B | |
| +20.62% | 333B | |
| +10.44% | 302B | |
| +18.45% | 246B | |
| +2.09% | 225B | |
| +13.03% | 218B | |
| +8.61% | 168B | |
| -4.76% | 155B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company - Special Call
